Humabiologics, Inc.

Private

Phoenix, ArizonaHealthcare & Life Scienceshttps://humabiologics.com/

Last Round

Grant

Jan 8, 2025

Total Funding Raised

$1M

Company Overview

Humabiologics, Inc. is a biotechnology company that develops and commercializes human-derived biomaterials, such as collagen and gelatin, for regenerative medicine therapies and research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, 3D Printing, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

human biomaterialshuman collagenbioinksregenerative medicinetissue engineering3D bioprintingxeno-free biomaterialshuman gelatinextracellular matricescell cultureECMmethacrylated collagenphotocrosslinkable biomaterialsethically sourced biomaterialscustom biomaterial formulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Humabiologics, Inc. Comps

Public and private peers based on sector, stage, and business model.

Humabiologics, Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Humabiologics, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jan 8, 2025
Seed	Jun 5, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Mohammad Albanna

CEO & Founder

Founding Team

Humabiologics, Inc. Investors

Notable investors and investment history

Humabiologics, Inc. investors
Investor	Rounds
RegenMed Engine	Grant
National Science Foundation	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 7, 2026
Monthly visitors increased 87% MoM.
Jul 21, 2025
Grew 27% QoQ from 11 to 14 employees.

View all signals

Humabiologics, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Humabiologics, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Humabiologics, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersPhoenix, Arizona

Employee Range6

Year Founded2018

Last FundingJan 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.